InflaRx N.V. said it will participate in several investor conferences in February 2026.

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in several investor conferences in February 2026. Details are as follows:

Guggenheim Securities Emerging Outlook: Biotech Summit 2026

February 11 - 12, 2026 in New York, NY

Fireside chat on Wednesday, February 11 at 11:30 AM ET

InflaRx will also conduct one-on-one investor meetings on February 11th. 

Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 25 - 26, 2026 in a virtual format

Virtual presentation on February 25 at 8:40 AM ET

InflaRx will also conduct one-on-one investor meetings on February 25th.

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon
COMTEX_472656847/2227/2026-01-31T01:39:10